NYSE:BDXMedical Equipment
Is Becton Dickinson’s (BDX) Aggressive Buybacks Quietly Redefining Its Capital Allocation Playbook?
In early February 2026, Becton Dickinson launched cash tender offers of up to US$1.60 billion to repurchase a wide range of outstanding senior notes and also completed a US$1,307.21 million share buyback program first announced in 2021, alongside reaffirming low single-digit plus GAAP revenue growth guidance for fiscal 2026.
Together with ongoing portfolio reshaping, including the planned separation of its Biosciences and Diagnostics businesses and board changes, these balance sheet moves...